Table 1 Transthoracic echocardiographic results
Variables | Tacrolimus (+) | Tacrolimus (−) | p-value |
|---|---|---|---|
Mitral valve level (prior to AMI) | |||
LVEDd (mm) | 34.6 ±1.46 | 35.2 ± 2.32 | 0.241 |
LVEDs (mm) | 23.4 ±2.32 | 24.5 ± 1.85 | 0.457 |
LVEVd (mL) | 50.6 ± 5.3 | 52.2 ± 5.8 | 0.316 |
LVEVs (mL) | 16.1 ± 1.4 | 15.4 ± 1.2 | 0.459 |
LVFS (%) | 33.6 ± 4.15 | 35.4 ± 4.63 | 0.583 |
LVEF (%) | 68.1 ± 1.2 | 68.1 ± 3.8 | 0.987 |
Papillary muscle level (prior to AMI) | |||
LVEDd (mm) | 33.4 ± 0.68 | 34.1 ± 0.75 | 0.419 |
LVEDs (mm) | 19.4 ± 0.51 | 19.9 ± 0.59 | 0.781 |
LVEVd (mL) | 44.0 ± 2.1 | 46.6 ± 2.3 | 0.263 |
LVEVs (mL) | 12.0 ± 0.23 | 12.6 ± 0.54 | 0.675 |
LVFS (%) | 32.0 ± 2.12 | 34.1 ± 1.06 | 0.358 |
LVEF (%) | 72.7 ± 1.3 | 72.8 ± 1.9 | 0.885 |
Mitral valve level (at day 14 after AMI) | |||
LVEDd (mm) | 35.7 ± 0.66 | 36.1 ± 0.91 | 0.472 |
LVEDs (mm) | 22.3 ± 0.54 | 23.0 ± 0.94 | 0.424 |
LVEVd (mL) | 53.2 ± 5.6 | 55.01 ± 4.1 | 0.649 |
LVEVs (mL) | 16.0 ± 1.4 | 18.0 ± 1.2 | 0.105 |
LVFS (%) | 38.2 ± 3.96 | 37.0 ± 4.24 | 0.312 |
LVEF (%) | 68.1 ± 1.2 | 67.2 ± 1.4 | 0.645 |
Papillary muscle level (at day 14 after AMI) | |||
LVEDd (mm) | 36.5 ±1.48 | 37.9 ± 1.67 | 0.217 |
LVEDs (mm) | 26.2 ± 3.03 | 31.4 ± 2.76 | 0.021 |
LVEVd (mL) | 56.6 ±5.8 | 61.4 ± 6.8 | 0.263 |
LVEVs (mL) | 26.2 ±8.9 | 39.6 ± 8.1 | 0.038 |
LVFS (%) | 30.4 ± 5.94 | 21.8 ± 6.46 | 0.046 |
LVEF (%) | 54.2 ±12.6 | 35.7 ±10.3 | 0.034 |